BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8643367)

  • 1. A chimeric tRNA(Lys3)-ribozyme inhibits HIV replication following virion assembly.
    Westaway SK; Larson GP; Li S; Zaia JA; Rossi JJ
    Nucleic Acids Symp Ser; 1995; (33):194-9. PubMed ID: 8643367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virion encapsidation of tRNA(3Lys)-ribozyme chimeric RNAs inhibits HIV infection.
    Westaway SK; Cagnon L; Chang Z; Li S; Li H; Larson GP; Zaia JA; Rossi JJ
    Antisense Nucleic Acid Drug Dev; 1998 Jun; 8(3):185-97. PubMed ID: 9669656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. tRNA(Lys3): the primer tRNA for reverse transcription in HIV-1.
    Kleiman L
    IUBMB Life; 2002 Feb; 53(2):107-14. PubMed ID: 12049192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of reverse transcriptase sequences in Pol with Gag and LysRS in the HIV-1 tRNALys3 packaging/annealing complex.
    Saadatmand J; Guo F; Cen S; Niu M; Kleiman L
    Virology; 2008 Oct; 380(1):109-17. PubMed ID: 18708237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.
    Giordano V; Jin DY; Rekosh D; Jeang KT
    Virology; 2000 Feb; 267(2):174-84. PubMed ID: 10662613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters.
    Chang Z; Westaway S; Li S; Zaia JA; Rossi JJ; Scherer LJ
    Mol Ther; 2002 Oct; 6(4):481-9. PubMed ID: 12377189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 reverse transcriptase shows no specificity for the binding of primer tRNA(Lys3).
    Arion D; Harada R; Li X; Wainberg MA; Parniak MA
    Biochem Biophys Res Commun; 1996 Aug; 225(3):839-43. PubMed ID: 8780699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primer selection by HIV-1 reverse transcriptase on RNA-tRNA(3Lys) and DNA-tRNA(3Lys) hybrids.
    Yusupova G; Lanchy JM; Yusupov M; Keith G; Le Grice SF; Ehresmann C; Ehresmann B; Marquet R
    J Mol Biol; 1996 Aug; 261(3):315-21. PubMed ID: 8780773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequences within Pr160gag-pol affecting the selective packaging of primer tRNA(Lys3) into HIV-1.
    Khorchid A; Javanbakht H; Wise S; Halwani R; Parniak MA; Wainberg MA; Kleiman L
    J Mol Biol; 2000 May; 299(1):17-26. PubMed ID: 10860720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse transcriptase is an important factor for the primer tRNA selection in HIV-1.
    Jiang M; Mak J; Huang Y; Kleiman L
    Leukemia; 1994 Apr; 8 Suppl 1():S149-51. PubMed ID: 7512177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspects of HIV-1 assembly that promote primer tRNA(Lys3) annealing to viral RNA.
    Saadatmand J; Kleiman L
    Virus Res; 2012 Nov; 169(2):340-8. PubMed ID: 22698876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of distal zinc finger of nucleocapsid protein in genomic RNA dimerization of human immunodeficiency virus type 1; no role for the palindrome crowning the R-U5 hairpin.
    Laughrea M; Shen N; Jetté L; Darlix JL; Kleiman L; Wainberg MA
    Virology; 2001 Mar; 281(1):109-16. PubMed ID: 11222101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes.
    Ramezani A; Ding SF; Joshi S
    Gene Ther; 1997 Aug; 4(8):861-7. PubMed ID: 9338016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
    Kang SM; Wakefield JK; Morrow CD
    Virology; 1996 Aug; 222(2):401-14. PubMed ID: 8806524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 reverse transcription initiation: a potential target for novel antivirals?
    Abbink TE; Berkhout B
    Virus Res; 2008 Jun; 134(1-2):4-18. PubMed ID: 18255184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a highly efficient anti-HIV pol hammerhead ribozyme.
    Müller-Kuller T; Capalbo G; Klebba C; Engels JW; Klein SA
    Oligonucleotides; 2009 Sep; 19(3):265-72. PubMed ID: 19732019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide sequences within the U5 region of the viral RNA genome are the major determinants for an human immunodeficiency virus type 1 to maintain a primer binding site complementary to tRNA(His).
    Zhang Z; Kang SM; LeBlanc A; Hajduk SL; Morrow CD
    Virology; 1996 Dec; 226(2):306-17. PubMed ID: 8955050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.